Cellgen’s novel precision medicine platform enables doctors to administer a simple blood test that will determine if a person’s genetic profile is a match for a given therapeutic in just 2 hours. This platform will help clinicians guide therapeutic treatment decisions to ensure the right person is taking the right medicine. Each disposable test will not only be guided by the genetics of each patient, but also by our proprietary machine learning technology, where every new patient improves the predictive accuracy. Cellgen’s speed, simplicity, and low cost will allow clinicians, to both, administer and process non-invasive, genomic-based testing in-house. If precision medicine is going to meet its promise and gain broad applicability, genomic technologies will have to meet patients at the point of care and move beyond Oncology.